Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-09-13

Clinical Trial Update: Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD [Phase 3]

View source ↗

Summary

Phase 3 trial investigating ipratropium/levalbuterol fixed-dose combination versus salbutamol/ipratropium free combination for acute bronchodilator effects in s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ipratropium/levalbuterol fixed-dose combination (ipratropium/levalbuterol)
  • salbutamol/ipratropium free combination (salbutamol/ipratropium)

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: WITHDRAWN